Moneycontrol
HomeNewsBusinessMarketsMadhusudan Kela sees FMCG, pharma as sweet spots in an expensive market
Trending Topics

Madhusudan Kela sees FMCG, pharma as sweet spots in an expensive market

Kela advises investors to expect moderate equity returns in the future, suggesting that over time, equities are likely to yield returns slightly higher than fixed income investments.

August 12, 2024 / 12:02 IST
Story continues below Advertisement
Madhusudan Kela, founder, MK Ventures

Ace investor and founder of MK Ventures, Madhusudan Kela, pointed out that in the current market scenario, discomfort lies in areas with high valuations, be it capital goods, defence or railways. In a market that's flooded with pockets of lofty valuations, Kela believes large-caps, especially, pharma and FMCG stocks, still offer reasonable risk-adjusted returns.

"I’m particularly interested in the pharma sector—select companies look compelling. FMCG stocks are also starting to move up, and the liquor sector looks like a long-term play," Kela said in an interaction with CNBC-TV18.

Story continues below Advertisement

Coming to overall market returns, Kela also warned investors against extrapolating past returns with anticipated future performance. "We’ve had tremendous gains in the market over the last 3-4 years, with a CAGR of over 30 percent even at the index level. However, if you’re investing long-term, your return expectations should be moderate," he said.

Kela explained that over time, equities should likely deliver returns that are a few basis points more than those on fixed income and hence, investors should keep their expectations in check.